The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 462, 33-42
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 56 references indexed in Scilit:
- Emerging insights into the molecular and cellular basis of glioblastomaGenes & Development, 2012
- A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growthBritish Journal of Cancer, 2011
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem CellsCell Stem Cell, 2011
- CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growthBritish Journal of Cancer, 2011
- Nuclear phosphoinositide 3-kinase β controls double-strand break DNA repairProceedings of the National Academy of Sciences, 2010
- Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastomaNeuro-Oncology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005